PharmExec
CONTINUE TO SITE >

OR WAIT 15 SECS

Marc Matar, Graham Tatham, Rachel Rowbottom, Sam Calderwood, Katerina Stavri

Marc Matar is a Partner, Graham Tatham is a Partner, Rachel Rowbottom is a Director, Sam Calderwood is a Senior Consultant, and Katerina Stavri is a Consultant in Simon-Kucher & Partners Life Sciences division based in the company’s London office.

Articles

Project Orbis: Implications for Access and Pricing in the UK

Post-Brexit, the UK’s MHRA is looking to join Project Orbis, a global program to speed up patient access to innovative cancer treatments. This article looks at the implications of Project Orbis for commercialization in the UK and the key considerations for industry in considering the project as a pathway.